These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9682276)

  • 21. Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.
    Oiwa Y; Eberling JL; Nagy D; Pivirotto P; Emborg ME; Bankiewicz KS
    Front Biosci; 2003 Sep; 8():a155-66. PubMed ID: 12957824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental Parkinson's disease in monkeys. Effect of ergot alkaloid derivative on lipid peroxidation in different brain areas.
    Marzatico F; Café C; Taborelli M; Benzi G
    Neurochem Res; 1993 Oct; 18(10):1101-6. PubMed ID: 8255359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression and recovery of Parkinsonism in a chronic progressive MPTP-induction model in the marmoset without persistent molecular and cellular damage.
    Franke SK; van Kesteren RE; Wubben JA; Hofman S; Paliukhovich I; van der Schors RC; van Nierop P; Smit AB; Philippens IH
    Neuroscience; 2016 Jan; 312():247-59. PubMed ID: 26431624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates.
    Zuddas A; Oberto G; Vaglini F; Fascetti F; Fornai F; Corsini GU
    J Neurochem; 1992 Aug; 59(2):733-9. PubMed ID: 1629743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.
    Kupsch A; Sautter J; Schwarz J; Riederer P; Gerlach M; Oertel WH
    Brain Res; 1996 Nov; 741(1-2):185-96. PubMed ID: 9001722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys.
    Mochizuki H; Imai H; Endo K; Yokomizo K; Murata Y; Hattori N; Mizuno Y
    Neurosci Lett; 1994 Feb; 168(1-2):251-3. PubMed ID: 8028787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys.
    Benazzouz A; Gross C; Féger J; Boraud T; Bioulac B
    Eur J Neurosci; 1993 Apr; 5(4):382-9. PubMed ID: 8261116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment.
    Elsworth JD; Taylor JR; Sladek JR; Collier TJ; Redmond DE; Roth RH
    Neuroscience; 2000; 95(2):399-408. PubMed ID: 10658619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonism.
    Graham WC; Robertson RG; Sambrook MA; Crossman AR
    Life Sci; 1990; 47(18):PL91-7. PubMed ID: 2250573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unilateral MPTP-induced parkinsonism in monkeys. A quantitative autoradiographic study of dopamine D1 and D2 receptors and re-uptake sites.
    Przedborski S; Jackson-Lewis V; Popilskis S; Kostic V; Levivier M; Fahn S; Cadet JL
    Neurochirurgie; 1991; 37(6):377-82. PubMed ID: 1780015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of D1 receptor stimulation in normal and MPTP monkeys.
    Bédard PJ; Boucher R
    Neurosci Lett; 1989 Sep; 104(1-2):223-8. PubMed ID: 2573015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine in the extrapyramidal motor function. A study based upon the MPTP-induced primate model of parkinsonism.
    Chiueh CC
    Ann N Y Acad Sci; 1988; 515():226-38. PubMed ID: 3259118
    [No Abstract]   [Full Text] [Related]  

  • 33. Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism.
    Frohna PA; Rothblat DS; Joyce JN; Schneider JS
    Synapse; 1995 Jan; 19(1):46-55. PubMed ID: 7709343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: effect of MPTP and dopaminomimetic treatments.
    Calon F; Morissette M; Goulet M; Grondin R; Blanchet PJ; Bédard PJ; Di Paolo T
    Exp Neurol; 2000 May; 163(1):191-9. PubMed ID: 10785458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deficits in operant behaviour in monkeys treated with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Schneider JS; Unguez G; Yuwiler A; Berg SC; Markham CH
    Brain; 1988 Dec; 111 ( Pt 6)():1265-85. PubMed ID: 3264739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
    Jourdain VA; Morin N; Grégoire L; Morissette M; Di Paolo T
    J Neurosurg; 2015 Dec; 123(6):1383-93. PubMed ID: 25932606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-exposed primate.
    Aziz TZ; Peggs D; Agarwal E; Sambrook MA; Crossman AR
    Br J Neurosurg; 1992; 6(6):575-82. PubMed ID: 1361741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of three dopamine receptor agonists in MPTP-treated monkeys.
    Arai N; Isaji M; Miyata H; Fukuyama J; Mizuta E; Kuno S
    J Neural Transm Park Dis Dement Sect; 1995; 10(1):55-62. PubMed ID: 8619909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complex.
    Calon F; Goulet M; Blanchet PJ; Martel JC; Piercey MF; Bédard PJ; Di Paolo T
    Brain Res; 1995 May; 680(1-2):43-52. PubMed ID: 7663983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential recovery of volitional motor function, lateralized cognitive function, dopamine agonist-induced rotation and dopaminergic parameters in monkeys made hemi-parkinsonian by intracarotid MPTP infusion.
    Schneider JS; Lidsky TI; Hawks T; Mazziotta JC; Hoffman JM
    Brain Res; 1995 Feb; 672(1-2):112-7. PubMed ID: 7749732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.